NEUROLITE

This brand name is authorized in Austria, Hong Kong SAR China, Japan, Singapore, Spain.

Active ingredients

The drug NEUROLITE contains one active pharmaceutical ingredient (API):

1
UNII B005P07V07 - BICISATE DIHYDROCHLORIDE
 
Read more about Technetium ⁹⁹ᵐTc bicisate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
V09AA02 Technetium (99mTc) bicisate V Various → V09 Diagnostic radiopharmaceuticals → V09A Central nervous system → V09AA Technetium (99mTc) compounds
Discover more medicines within V09AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
ES Centro de información online de medicamentos de la AEMPS 60882
HK Department of Health Drug Office 43086
JP 医薬品医療機器総合機構 4300443A1024, 4300443A2020
SG Health Sciences Authority 12644P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈